@gemmatarr Congratulations to a fantastic team. Great to see recognition of all the hard work and innovation. Jo - consistently amazing as a leader and colleague - very well done xx
NICE have released their updated guidance on Heart Failure (NG106), bringing key changes to improve care and outcomes for people living with HF, and support clinicians in delivering this care.
Find the guidance here: https://t.co/NYeIYR54H3
There are several positive developments in the guidance including:
1. NICE recognise and name HF pharmacists as core to HF team.
2. Four pillars HF therapy recommended for HFrEF and 4 pillars to be considered for HFmrEF patients. A stepwise approach is no longer required. Use the person's clinical status to decide how and when to optimise medicine doses
3. Two pillars recognised for HFpEF (MRA and SGLT2-)
4. ARNI can now be initiated in primary care (but GPs should consider seeking specialist HF advice first).
5. NICE recommends iv iron in HFrEF with iron deficiency (if Hb <150g/l, TSAT <20% OR ferritin <100ng/l).
This is a positive step in the right direction for heart failure care and treatment but we must continue to work together to advocate for further improvements and ensure heart failure becomes a national priority.
#25in25 #HeartFailure #NICEGuidance
@alisonleary1@wearesiam@DeborahMeaden I agree. We need solutions that maximise clinician time doing what we trained for instead of HR and ticking boxes for « quality » purposes that do not, in reality, enhance care. More time patient facing and less time writing about it.
We cannot wait for the Leng review. @RCollEM, @RCEMpresident & @RCEM_VP - urgent action is needed NOW to safeguard patient safety.
It is not safe for Physician Associates to be working at ‘Tier 2’, and discharging patients without a F2F senior review